Efficacy News and Research

RSS

Restricting testing to 'classic triad' of symptoms may have missed some COVID-19 cases

Extending the symptoms that trigger a PCR test for COVID-19 could help detect around a third more cases of the disease.

18 Feb 2021

Launch of EMSO rapidly accesses ground-breaking cancer research from research to practice

ESMO, the leading organization for medical oncology, has launched an important new service for rapidly disseminating research to accelerate the transition of results into practice for the benefit of cancer patients.

18 Feb 2021

New proton therapy targets treatment-resistant cancer cells

Mayo Clinic researchers have developed a novel proton therapy technique to more specifically target cancer cells that resist other forms of treatment.

18 Feb 2021

Researchers test the efficacy of commercial sleep trackers

Wearable sleep tracking devices - from Fitbit to Apple Watch to never-heard-of brands stashed away in the electronics clearance bin - have infiltrated the market at a rapid pace in recent years.

18 Feb 2021

CDC study says face mask mandates reduced COVID-19 hospitalizations in the U.S.

A new study by researchers at the CDC examined whether the implementation of the mask mandate is tied to COVID-19-related hospitalization growth rates among different age groups.

17 Feb 2021

Advancements in DNA vaccines against COVID-19

The rapid spread of the pathogen and the increasing number of cases highlight the need for an effective and safe vaccine. As vaccination efforts roll out in many countries, new types of vaccines, like deoxyribonucleic acid (DNA) vaccines, are under research..

17 Feb 2021

Convalescent plasma shows CD8+ T cell responses to SARS-CoV-2 variants

Researchers in the United States have conducted a study suggesting that individuals who have recovered from or been vaccinated against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) should maintain effective CD8+ T-cell responses against the major variants that have recently emerged.

17 Feb 2021

Purely mathematical perspective on delaying the second dose of the SARS-CoV-2 vaccine

High demand for the vaccines has raised questions as to whether it would be better in the long term to ensure that as much of the population as possible has received the first dose, i.e., vaccinate twice as many people with a lower rate of efficacy.

17 Feb 2021

$1.3 million grant funds clinical trial to test psilocybin for treating patients with phantom limb pain

The Psychedelics and Health Research Initiative at UC San Diego has received a $1.3 million grant from the Steven & Alexandra Cohen Foundation to fund a clinical trial investigating the therapeutic potential of psilocybin in treating phantom limb pain.

17 Feb 2021

Probiotics may be beneficial in COVID-19 treatment

A new study explores the role of common probiotics in managing the disease, which could prove to be of great value, given the emergence of new variants and the broad spectrum of clinical disease in COVID-19.

17 Feb 2021

New type of antibody marks infected cells, makes them visible to the immune system

Scientists at Cardiff University have discovered a unique way to target a common virus that affects one in 200 newborn babies in the UK but for which there is only limited treatments available.

17 Feb 2021

Understanding stroke and heart disease in women remains a major research priority

Understanding the sex differences in cardiovascular disease presentation and outcomes remains a major research priority demonstrated by the record number of submissions for this year's Go Red for Women® special issue of the American Heart Association's flagship journal Circulation, published online today.

17 Feb 2021

New system distinguishes suspicious pigmented lesions from non-suspicious ones

Melanoma is by far the deadliest form of skin cancer, killing more than 7,000 people in the United States in 2019 alone.

17 Feb 2021

Molecular imaging can predict response to novel metastatic breast cancer treatment

Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2-negative metastatic breast cancer patients who are resistant to hormonal therapy.

17 Feb 2021

Detection of emerging SARS-CoV-2 variant in New York

Researchers at the California Institute of Technology in Pasadena have developed a software tool called "Variant Database" that has detected an emerging lineage of severe acute respiratory coronavirus 2 (SARS-CoV-2) isolates in New York.

16 Feb 2021

New analysis shows lack of strong evidence to support anorexia nervosa treatment guidelines

New analysis published in The Lancet Psychiatry has shown a lack of strong evidence to support current guidance on psychological therapies for treating anorexia nervosa over expert treatment as usual.

16 Feb 2021

UV light can be used to disinfect SARS-CoV-2 contaminated surfaces, says study

Using different UV exposure times and dosages, researchers showed that surfaces like glass, plastic, stainless steel, and N95 respirator material could be quickly and easily disinfected.

16 Feb 2021

Artemisia plant extracts show potential anti-SARS-CoV-2 activity in vitro

A team of scientists from Germany and the USA recently explored the effectiveness of traditional plant medicines in treating SARS-CoV-2 infection.

16 Feb 2021

British and South African SARS-CoV-2 variants show some resistance to neutralizing antibodies

Researchers in France report impaired neutralization of two new SARS-CoV-2 variants by antibodies induced by vaccination or natural infection.

16 Feb 2021

ERS Genomics and ZeClinics sign CRISPR/Cas9 license agreement

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and ZeClinics, a contract research organization using zebrafish to carry out services focused on analyzing the safety, efficacy and biomedical relevance of new compounds, today announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics’ CRISPR/Cas9 patent portfolio.

From ZeClinics SL 16 Feb 2021

Efficacy News and Research

Restricting testing to 'classic triad' of symptoms may have missed some COVID-19 cases

Launch of EMSO rapidly accesses ground-breaking cancer research from research to practice

New proton therapy targets treatment-resistant cancer cells

Researchers test the efficacy of commercial sleep trackers

CDC study says face mask mandates reduced COVID-19 hospitalizations in the U.S.

Advancements in DNA vaccines against COVID-19

Convalescent plasma shows CD8+ T cell responses to SARS-CoV-2 variants

Purely mathematical perspective on delaying the second dose of the SARS-CoV-2 vaccine

$1.3 million grant funds clinical trial to test psilocybin for treating patients with phantom limb pain

Probiotics may be beneficial in COVID-19 treatment

New type of antibody marks infected cells, makes them visible to the immune system

Understanding stroke and heart disease in women remains a major research priority

New system distinguishes suspicious pigmented lesions from non-suspicious ones

Molecular imaging can predict response to novel metastatic breast cancer treatment

Detection of emerging SARS-CoV-2 variant in New York

New analysis shows lack of strong evidence to support anorexia nervosa treatment guidelines

UV light can be used to disinfect SARS-CoV-2 contaminated surfaces, says study

Artemisia plant extracts show potential anti-SARS-CoV-2 activity in vitro

British and South African SARS-CoV-2 variants show some resistance to neutralizing antibodies

ERS Genomics and ZeClinics sign CRISPR/Cas9 license agreement

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News